Since LNK mutations were described in MPN but escaped detection by the Truseq Amplicon Cancer Panel, we performed Sanger sequencing for the hotspot region LNK exon 2 for all samples. This evidence concerns the gene SH2B3 and myeloproliferative neoplasm.